NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Appoints New Member to Board of Directors

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, this morning announced the appointment of Jamieson Bondarenko, CFA, CMT, to the company’s Board of Directors. Through his merchant capital company, JGRNT Capital Corp., Bondarenko currently offers strategic capital markets and corporate development advice to early-stage life sciences companies. He has also served as Principal, Managing Director of Equity Capital Markets at Eight Capital and Equity Capital Markets as well as Investment Banking positions at Dundee Capital Markets, Wellington West Capital Markets and HSBC Securities. “Jamieson brings extensive capital markets experience to BriaCell,” BriaCell Chairman Dr. Saeid Babaei stated in the news release. “His expertise will be a valuable resource for BriaCell in the current investment environment as we execute our mission to bring innovative therapeutics to patients who tirelessly fight the deadliest forms of advanced breast cancer with no effective treatment options.”

To view the full press release, visit http://nnw.fm/jSjK6

About BriaCell Therapeutics Corp.

BriaCell is an immuno-oncology-focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell is currently conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a combination study with pembrolizumab [Keytruda; manufactured by Merck & Co., Inc.] or ipilimumab [Yervoy; manufactured by Bristol-Myers Squibb Company]. The combination study is listed in ClinicalTrials.gov as NCT03328026. BriaCell is developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS, which is expected to cover over 90 percent of the patient population, is designed to produce a potent and selective immune response against the cancer of each patient while eliminating the time, expense and complex manufacturing logistics associated with other personalized immunotherapies. For more information, visit the company’s website at www.BriaCell.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

More News From Finance - Asia Logue

China bars millions from travel for 'social credit' offenses

Feb 22, 2019

BEIJING — Forgot to pay a fine in China? Then forget about buying an airline ticket. Would-be air travelers were blocked from buying tickets 17.5 million times last year under a controversial "social credit" system the ruling Communist Party says will improve public behavior. Some 5.5 million people were barred from buying train tickets, according to the National Public Credit Information Center. In an annual report, it said 128 people were blocked from leaving China because they were behind on their taxes. The ruling party says penalties and rewards under "social credit" will improve order in a fast-changing society. Three...

China's new policy against gender bias meets fans, sceptics

Feb 22, 2019

BEIJING — China has announced new measures against gender discrimination in Chinese workplaces that forbid employers from asking potential female hires questions such as if they are married or have children. At some companies in China, the answers to these questions can be disqualifying. Other firms are explicit in their job postings that they are looking only for men. Many welcomed the government notice, published Thursday, which forbids companies and recruitment agencies from taking certain discriminatory actions against female employees and job candidates. But female workers and analysts alike were skeptical that such measures could be strictly enforced. "A notice...

Global stocks mostly rise ahead of US-China tariff war talks

Feb 22, 2019

BEIJING — Most global stock markets rose Thursday as U.S. and Chinese officials entered two days of negotiations aimed at ending a bruising tariff battle. In midday trading in Europe, Britain's FTSE 100 fell 0.7 percent to 7,178 after EU Commission President Jean-Claude Juncker said he remains downbeat on the prospect of Britain avoiding a chaotic exit from the bloc next month. Germany's DAX index advanced 0.4 percent to 11,443 while France's CAC 40 added 0.1 percent to 5,201. On Wall Street, the future for the Standard & Poor's 500 index was roughly unchanged. The future for the Dow Jones...

Report: US company to stop sales of genetic tech in Xinjiang

Feb 22, 2019

BEIJING — Thermo Fisher Scientific Inc. says it will no longer sell or service genetic sequencers in China's mostly Muslim region of Xinjiang following criticism that they were used for surveillance that enabled human rights abuses, The Wall Street Journal reported. The company in Waltham, Massachusetts, cited its "values, ethics code and policies," according to the Journal. The company said it recognized the importance of considering how products "are used — or may be used — by our customers." Thermo Fisher faced criticism from human rights groups and American lawmakers for supplying the equipment used to identify individuals in Xinjiang....

Asian stocks change little ahead of more US-China talks

Feb 22, 2019

BEIJING — Asian stock markets were little-changed Thursday following a listless day on Wall Street ahead of U.S.-Chinese negotiations aimed at ending a tariff battle. Tokyo's Nikkei 225 index lost 0.1 percent to 21,402.69 after a gauge of manufacturing activity fell to a three-year low, suggesting Japanese economic growth is slowing. The Shanghai Composite Index was unchanged at 2,762.67. Sydney's S&P-ASX 200 added 0.4 percent to 6,120.50 while Hong Kong's Hang Seng gained 9 points to 28,526.95. Seoul's Kospi was unchanged at 2,230.15. Benchmarks in New Zealand and Taiwan advanced while Southeast Asian markets mostly declined. Investors looked ahead to...

Sign up now!

Advertisement